Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy: Hematological Oncology

M Bocchia, A Candoni, E Borlenghi, M Defina, C Filì, C Cattaneo, V Sammartano, R Fanin, M Sciumè, A Sicuranza, S Imbergamo, M Riva, N Fracchiolla, R Latagliata, E Caizzi, F Mazziotta, G Alunni, E Di Bona, M Crugnola, M RossiU Consoli, G Fontanelli, G Greco, G Nadali, F Rotondo, E Todisco, C Bigazzi, E Capochiani, A Molteni, M Bernardi, M Fumagalli, M Rondoni, B Scappini, A Ermacora, F Simonetti, M Gottardi, D Lambertenghi Deliliers, M Michieli, C Basilico, C Galeone, C Pelucchi, G Rossi

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy: Hematological Oncology'. Together they form a unique fingerprint.

Medicine & Life Sciences